NO20003881L - Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber - Google Patents

Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber

Info

Publication number
NO20003881L
NO20003881L NO20003881A NO20003881A NO20003881L NO 20003881 L NO20003881 L NO 20003881L NO 20003881 A NO20003881 A NO 20003881A NO 20003881 A NO20003881 A NO 20003881A NO 20003881 L NO20003881 L NO 20003881L
Authority
NO
Norway
Prior art keywords
bibapcitide
thrombi
imaging
treatment
pharmaceutical compositions
Prior art date
Application number
NO20003881A
Other languages
English (en)
Other versions
NO20003881D0 (no
Inventor
Richard T Dean
John Lister-James
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9802681A external-priority patent/GB9802681D0/en
Application filed by Diatide Inc filed Critical Diatide Inc
Publication of NO20003881D0 publication Critical patent/NO20003881D0/no
Publication of NO20003881L publication Critical patent/NO20003881L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Oppfinnelsen tilveiebringer nye forløper-reagenser anvendt for fremstilling av avbildningsmidler avledet fra apcitid. Avbildingsmidler fremstilt ved å anvende. forløper-reagensene ifølge oppfinnelsen er nyttige for in vivo deteksjon og diagnose av thromber. Forløper-reagensene ifølge oppfinnelsen kan også anvendes i fremstilling av anti-thrombosemidler avledet fra apcitid. Nærværet av de frie karboksylatgruppene gir forløper-reagensene større oppløselighet enn bibapcitid i vandige medier.
NO20003881A 1998-02-06 2000-07-28 Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber NO20003881L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/020,086 US6028056A (en) 1998-02-06 1998-02-06 Pharmaceutical compositions for imaging and treating thrombi
GB9802681A GB9802681D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compoations for imaging and treating thrombi
PCT/US1999/002583 WO1999039747A1 (en) 1998-02-06 1999-02-05 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi

Publications (2)

Publication Number Publication Date
NO20003881D0 NO20003881D0 (no) 2000-07-28
NO20003881L true NO20003881L (no) 2000-07-28

Family

ID=26313082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003881A NO20003881L (no) 1998-02-06 2000-07-28 Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber

Country Status (25)

Country Link
US (1) US6028056A (no)
EP (1) EP1053027B1 (no)
JP (1) JP2003532617A (no)
KR (1) KR100452390B1 (no)
CN (1) CN1103606C (no)
AR (1) AR018546A1 (no)
AT (1) ATE279214T1 (no)
AU (1) AU761778B2 (no)
BR (1) BR9908352A (no)
CA (1) CA2319544C (no)
DE (1) DE69921096T2 (no)
DK (1) DK1053027T3 (no)
EA (1) EA005406B1 (no)
ES (1) ES2229681T3 (no)
HU (1) HUP0100887A3 (no)
IL (1) IL137076A (no)
NO (1) NO20003881L (no)
NZ (1) NZ505085A (no)
PE (1) PE20000250A1 (no)
PL (1) PL342253A1 (no)
PT (1) PT1053027E (no)
SI (1) SI1053027T1 (no)
SK (1) SK284463B6 (no)
TW (1) TWI246425B (no)
WO (1) WO1999039747A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6243335B2 (ja) 2011-08-17 2017-12-06 ピラマル イメージング ソシエテ アノニム 血小板固有の糖タンパク質IIb/IIIaに結合する化合物と血栓造影のためのその使用
CA2900595A1 (en) 2013-02-12 2014-08-21 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia
CN117177775A (zh) * 2021-04-14 2023-12-05 启德医药科技(苏州)有限公司 连接子、缀合物及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5645815A (en) * 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
EP0641222B1 (en) * 1992-05-21 2000-09-06 Diatide, Inc. TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING

Also Published As

Publication number Publication date
PT1053027E (pt) 2005-01-31
JP2003532617A (ja) 2003-11-05
ATE279214T1 (de) 2004-10-15
CN1290179A (zh) 2001-04-04
NO20003881D0 (no) 2000-07-28
AU2660499A (en) 1999-08-23
TWI246425B (en) 2006-01-01
HK1032198A1 (en) 2001-07-13
PE20000250A1 (es) 2000-06-02
CA2319544C (en) 2006-07-04
CA2319544A1 (en) 1999-08-12
US6028056A (en) 2000-02-22
SK11392000A3 (sk) 2001-03-12
KR100452390B1 (ko) 2004-10-08
WO1999039747A1 (en) 1999-08-12
EA005406B1 (ru) 2005-02-24
KR20010040676A (ko) 2001-05-15
EP1053027B1 (en) 2004-10-13
IL137076A0 (en) 2001-06-14
DE69921096D1 (de) 2004-11-18
DE69921096T2 (de) 2006-02-02
IL137076A (en) 2004-08-31
EA200000820A1 (ru) 2001-02-26
HUP0100887A3 (en) 2003-08-28
SI1053027T1 (en) 2005-04-30
DK1053027T3 (da) 2005-01-17
BR9908352A (pt) 2000-11-28
AU761778B2 (en) 2003-06-12
NZ505085A (en) 2002-10-25
ES2229681T3 (es) 2005-04-16
EP1053027A1 (en) 2000-11-22
SK284463B6 (sk) 2005-04-01
PL342253A1 (en) 2001-06-04
CN1103606C (zh) 2003-03-26
HUP0100887A2 (hu) 2001-06-28
AR018546A1 (es) 2001-11-28

Similar Documents

Publication Publication Date Title
CN108918487B (zh) 一种蛋白质包裹的荧光金纳米簇、制备方法及其应用
Hennard et al. Synthesis and Activities of Pyoverdin− Quinolone Adducts: A Prospective Approach to a Specific Therapy Against Pseudomonas a eruginosa
DE60113934D1 (de) Düse zur Reinigung des Beobachtungsfensters eines Endoskopes
NO20022592D0 (no) Forbindelser og fremgangsmåter for behandling og diagnose av Chlamydia-infeksjoner
EA200400536A1 (ru) Макролиды
WO2002066511A3 (en) Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
Gounaris et al. Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis
DE60116313D1 (de) Verbindungen zur behandlung der alzheimerischen krankheit
ATE523034T1 (de) System und verfahren zur weitwinkelabbildung von körperlumen
CA3207999A1 (en) Bivalent fibroblast activation protein ligands for targeted delivery applications
EA200600524A1 (ru) Способы лечения эндометриоза
DE60127986D1 (de) Bildgebende verfahren, diagnose und behandlung von krankheiten
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
WO2002055988A3 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
WO2004064869A3 (en) Amyloid-binding, metal-chelating agents
EE200000587A (et) Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
RU95110937A (ru) Хинолоновые и акридиноновые соединения, способ их получения, фармацевтическая композиция и промежуточные соединения
NO20003881L (no) Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber
Leskinen Complications of acute otitis media in children
DE60207288D1 (de) Gewebespezifische fluoreszierende chelate
CA2435320A1 (en) Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer
ES2753274T5 (es) Composición y procedimiento de hibridación
NO20021355D0 (no) Forbedret diagnostisk metode for detektering av dysplastisk epitelialvev
HK1045712A1 (zh) Fimh粘附素基疫苗
Erdem et al. Predictive value of morphologic characteristics in rectosigmoid adenomatous polyps for the probability of synchronous polyps or cancer in the proximal colon

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application